Page 129 - FINAL PROGRAMME 2017

TUESDAY, 4 JULY 2017
SELECTED ORAL COMMUNICATIONS
15:15 - 16:30 Room W+X
Session 50: Mosaicism in gametes and embryos
Chairman: S. Altmäe (Estonia)
Chairman: B. Woodward (United Kingdom)
15:15
15:30
15:45
16:00
16:15
O-181 Comprehensive comparison of inner cell mass and trophectoderm reveals the complex nature of chromosomal mosaicism in human embryos
M. Popovic1, A. Dheedene2, C. Christodoulou1, M. Van Der Jeught1, F. Van Nieuwerburgh3, D. Deforce3, P. De Sutter1, E. Van Den Abbeel1, B. Menten2, B. Heindryckx1
1Ghent University Hospital, Department for Reproductive Medicine, Ghent, Belgium 2Ghent University Hospital, Center for Medical Genetics, Ghent, Belgium
3Ghent University, Laboratory of Pharmaceutical Biotechnology, Ghent, Belgium
O-182 The extent of chromosomal mosaicism in uence the clinical outcome of in vitro fertilization treatments
F. Spinella1, S. Bono1, A. Biricik1, E. Cotroneo1, M. Baldi1, E. Cursio2, M.G. Minasi2, E. Greco2, F. Fiorentino1 1GENOMA Group, Molecular Genetics Laboratory, Rome, Italy
2European Hospital, Reproductive Medicine, Rome, Italy
O-183 Mosaicism across individual chromosome in trophectoderm biopsies by Next generation sequencing: changes with chromosome length
C.Y. Chen1, T.H. Chuang1, M.J. Lee1, H.H. Lai1, H.L. Wang1, C.L. Hsieh1
1Stork Ladies Clinic, Assisted Reproductive Technology, Hsinchu, Taiwan R.O.C.
O-184 Increased risk of aneuploidy in preimplantation embryos from heterochromatic chromosomal variants carriers
M. Sandalinas1, E. Garcia-Guixé1, E. Fernandez2, E. Toro Toro1, E. Alsina Xiol1, E. Balius Fort1, M. Palahí Bages1, D. Campos Rodero1, L. Alvarez1, C. Giménez I Sevilla1
1Reprogenetics Spain, Barcelona, Spain 2Geniality Diagnóstico Genético, Madrid, Spain
O-185 Reevaluation of the frequency and characteristics of aneuploidy of surgically retrieved spermatozoa in light of enhanced molecular genetic techniques
S. Cheung1, Z. Rosenwaks1, G. Palermo1
1Weill Cornell Medicine, The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, U.S.A.
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 129
SCIENTIFIC PROGRAMME TUESDAY, 4 JULY